store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Evixapodlin (PD-1/PD-L1-IN 7) 是一种人 PD-1/PD-L1蛋白/蛋白相互作用抑制剂(IC50:0.213)。Evixapodlin 具有抗癌和抗病毒活性。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 987 | 现货 | ||
5 mg | ¥ 2,530 | 现货 | ||
10 mg | ¥ 3,960 | 现货 | ||
25 mg | ¥ 7,630 | 现货 | ||
50 mg | ¥ 9,870 | 现货 | ||
100 mg | ¥ 13,800 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 3,580 | 现货 |
产品描述 | Evixapodlin (PD-1/PD-L1-IN 7) is a human PD-1/PD-L1 protein/protein interaction inhibitor (IC50: 0.213).Evixapodlin has anticancer and antiviral activities. |
靶点活性 | PD-1/PD-L1 (human):0.213 nM (IC50) |
体外活性 | Evixapodlin exhibits an ability to increase the production of IFN-γ and Granzyme B in both CD8+ and CD4+ T cells in individuals with chronic hepatitis B (CHB). Additionally, Evixapodlin enhances the frequency of Granzyme B-positive cells among HBV-specific CD8+ and CD4+ T cells.[1] |
体内活性 | Evixapodlin (10-50 mg/kg; intraperitoneal injection, daily, for 6 days) treatment results in over 90% occupancy of the PD-L1 target on tumor cells. Evixapodlin effectively suppresses tumor growth in a mouse colorectal tumor model (MC38) that expresses human PD-L1.[1] |
别名 | PD-1/PD-L1-IN 7, GS-4224 |
分子量 | 691.61 |
分子式 | C34H36Cl2N8O4 |
CAS No. | 2374856-75-2 |
store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45.0 mg/mL (65.1 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.4459 mL | 7.2295 mL | 14.459 mL | 36.1475 mL |
5 mM | 0.2892 mL | 1.4459 mL | 2.8918 mL | 7.2295 mL | |
10 mM | 0.1446 mL | 0.723 mL | 1.4459 mL | 3.6148 mL | |
20 mM | 0.0723 mL | 0.3615 mL | 0.723 mL | 1.8074 mL | |
50 mM | 0.0289 mL | 0.1446 mL | 0.2892 mL | 0.723 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Evixapodlin 2374856-75-2 Apoptosis Cell Cycle/Checkpoint Immunology/Inflammation Microbiology/Virology Antiviral HBV PD-1/PD-L1 PD-1/PD-L1-IN 7 GS-4224 GS4224 GS 4224 Inhibitor inhibitor inhibit